Topical Xibrom 0.1%, an investigational NSAID, significantly and rapidly decreased post-cataract surgery inflammation and reduced ocular pain

被引：0
|
作者：
Donnenfeld, E
Holland, EJ
Stewart, R
Grillone, LR
机构：
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2005年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
791
引用
收藏
页数：1
相关论文
共 10 条
  • [1] Clobetasol propionate for post-cataract surgery pain and inflammation
    Azhar, Syeda D.
    Shahid, Nayab
    Sadiq, Aiman
    Khan, Aimen W.
    Sultan Dar, Marrium
    Fadlalla Ahmed, Tagwa K.
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (11): : 6395 - 6398
  • [2] Investigating recent advances in pharmacotherapy for acute and chronic ocular pain post-cataract surgery
    Donthineni, Pragnya R.
    Munger, Wade
    Galor, Anat
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (16) : 2107 - 2113
  • [3] Efficacy and safety of diclofenac 0.1% ABAK® versus preserved diclofenac 0.1% eye drops in controlling post-cataract surgery inflammation.
    Goldschmidt, P
    Elena, PP
    Baldwin, H
    Delval, L
    Colin, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U160 - U160
  • [4] Safety and efficacy of a novel submicron loteprednol etabonate gel in the treatment of inflammation and pain post-cataract surgery
    Vittitow, Jason L.
    LoBue, Thomas
    Martel, Joseph
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [5] Clinical Response of 0.075% Bromfenac in DuraSite® on Ocular Inflammation and Pain Post Cataract Surgery
    Hutcheson, Judith A.
    McMullen, Dragana
    Hosseini, Kamran
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [6] Use of topical bromfenac for treating ocular pain and inflammation beyond cataract surgery: a review of published studies
    Schechter, Barry A.
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1439 - 1460
  • [7] Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients
    Numaga J.
    Journal of Ophthalmic Inflammation and Infection, 2011, 1 (4) : 147 - 155
  • [8] OCS-01 (Novel Topical Dexamethasone Formulation) in Inflammation and Pain Post Cataract Surgery: A Randomized, Double-Masked, Vehicle-Controlled Study
    Korenfeld, Michael
    Gira, Joe
    Jong, Kevin
    Martel, Joseph
    Vold, Steven
    Walters, Tom
    Usner, Dale
    Donnenfeld, Eric
    CLINICAL THERAPEUTICS, 2022, 44 (12) : 1577 - 1587
  • [9] CEfficacy of topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in post-refractive surgery chronic dry eye patients with ocular pain (Vol 24, 28, 2024)
    Zhao, Lu
    Chen, Jiawei
    Duan, Hongyu
    Yang, Tingting
    Ma, Baikai
    Zhou, Yifan
    Bian, Linbo
    Cai, Xiying
    Qi, Hong
    BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [10] A Clinical Study Evaluating the Safety and Efficacy of a Punctal Plug Delivery System of Nepafenac (N-PPDS) in Controlling Post-Operative Ocular Pain and Inflammation in Subjects Undergoing Routine Unilateral Cataract Surgery
    Utkhede, Deepank
    Williams, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
1